A compound initially developed as a "binder" for highway paving may introduce a novel solution for bone-and-ligament-and-tendon orthopedic surgical procedures. OsteoCrete™ is being developed as a magnesium-based bone void filler subject to FDA 510(k) approval that will provide a new surgeon-friendly tool for improving success rates for these procedures.